Rare disease news

FDA approvals, research breakthroughs, clinical trials, and advocacy updates

Curated and summarized by AI for patients and caregivers

🔍
AllDrug approvalsClinical trialsResearchGrants & fundingAdvocacy & policyPipeline
Show:All newsBreaking onlyImportant & breaking
Date:7 days30 days90 daysAll time

1 article from the last 30 days matching "flu vaccine"

PolicyEMAMay 11

EU recommendations for 2026/2027 seasonal flu vaccine composition

The European Medicines Agency has updated its recommendations for which flu virus strains should be included in flu vaccines for the 2026-2027 season. These recommendations apply to different types of flu vaccines, including those made using eggs and live weakened virus versions. The update was announced in May 2026 to help vaccine manufacturers prepare the right vaccines for the upcoming flu season.

WHY IT MATTERSPatients with rare immunodeficiency disorders or chronic conditions that increase flu risk should know which vaccine formulations their doctors may recommend, as the strain composition affects how well the vaccine protects them.
Good to know

Get personalized rare disease news

Follow your conditions to see news about the diseases that matter to you — FDA approvals, trial openings, and research breakthroughs.

Create free account →Browse diseases